Andelyn Biosciences, Inc., a cell and gene therapy CDMO, has expanded its AAV Curator Platform offering and License Agreement with the Broad Institute of MIT and Harvard to include the Stanton Lab CNS ...

VIVOZON Pharmaceutical announced that its non-opioid analgesic, UNAFRA Inj., was approved on December 12, 2024.

Neurofilament light (NFL) is a powerful and sensitive biomarker for tracking neuronal health and disease progression.

Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic ...

Certain drugs and a host of nonpharmacologic therapies are key to treating patients who have nociplastic pain, a relatively ...

Multiple sclerosis (MS) is a chronic autoimmune disorder of the central nervous system (CNS) and a common cause for neurological disabilities in young adults. Although it is known that the peripheral ...

Researchers at Jilin University (Changchun, China) developed a highly sensitive, rapid, and accurate method for analyzing ...

The name is doing the rounds, though on limited scale these. This is the name of a disease considered to affect only one or ...

Nura Bio, Inc. (Nura Bio), a clinical-stage, biopharmaceutical company developing neuroprotective, small molecule therapies for the treatment of debilitating neurological diseases, announced today the ...

Neurodegenerative diseases are a heterogeneous group of disorders that are characterized by the progressive degeneration of the structure and function of the central nervous system or peripheral ...